Clinical Trials in Chicago

Showing 9141-9160 of 15,574 trials

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

NCT02253992

The purpose of this study is to determine which doses of Urelumab and Nivolumab are safe and tolerable when they are given together.

Advanced Solid TumorsAdvanced B-cell NHL

Bristol-Myers Squibb232 participantsStarted Sep 2014

Palo Alto, California, United States • Tampa, Florida, United States • Chicago, Illinois, United States +14 more locations

COMPLETEDPhase 32.2 miles

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

NCT00014222

RATIONALE: 1. . To compare the effects on breast cancer of three different combinations of drugs which are commonly used to treat this disease. 2. . It is not yet known which treatment regimen is most effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy given with or without epoetin alfa in treating women who have undergone surgery for stage I, stage II, or stage III breast cancer.

Breast Cancer

NCIC Clinical Trials Group2,104 participantsStarted Dec 2000

Fort Smith, Arkansas, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +75 more locations

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Find Trials by Condition in Chicago

Losartan to Reverse Sickle Nephropathy

Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)

PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings

A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

Single Arm on the Tolerability of Weekly Nab-paclitaxel

Confirmation of Ventilation and Intubation by Determination With Ultrasonography

A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib

A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma